No additional benefit with use of a fibrin sealant to decrease peri-operative blood loss during primary total knee...

Area of Science:

• Orthopedic Surgery
• Surgical Hemostasis

Background:

• Significant blood loss is a common complication following total knee arthroplasty (TKA).
• Minimizing perioperative blood loss and transfusion requirements is crucial for patient outcomes.

Purpose of the Study:

• To evaluate the efficacy of fibrin sealant in reducing blood loss, transfusion rates, and length of stay after TKA.
• To determine if fibrin sealant offers a clinical benefit in TKA patients.

Main Methods:

• A retrospective study comparing 113 TKA patients who received fibrin sealant to 70 patients who did not.
• Analysis of hemoglobin levels, intraoperative, postoperative, and total perioperative blood loss.
• Comparison of blood transfusion requirements between the two groups.

Main Results:

• No significant difference was observed in hemoglobin levels across three postoperative days between groups.
• Intraoperative, postoperative, and total perioperative blood loss showed no significant variation.
• Mean blood transfusion units per patient were 2.5 ± 2.4 in the fibrin sealant group versus 2.0 ± 0.8 in the non-sealant group.

Conclusions:

• Fibrin sealant demonstrated no significant efficacy in reducing blood loss or transfusion requirements in TKA.
• The study concluded that fibrin sealant provided no discernible benefit for TKA patients.
• The clinical use of fibrin sealant was discontinued based on these findings.